Pablo Lopez-Balboa

4PUBLICATIONS

18CO-AUTHORS

Infant and child healthNeonatologyRegenerative medicine (incl. stem cells)Electrochemistry

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jun 23, 2026

Intravenous gentamicin therapy in children with severe recessive dystrophic epidermolysis bullosa patients with nonsense COL7A1 mutations.

|Jun 04, 2026

Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with Recessive Dystrophic Epidermolysis Bullosa (MissionEB): a qualitative sub study of a randomised, double-blind, placebo controlled, crossover, phase 3 trial.

|May 21, 2025

Mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: MissionEB protocol for a randomised, double-blinded, placebo-controlled, two-centre, crossover trial with an internal phase I dose de-escalation phase and open-label extension.

Maria L Bageta, Pablo López-Balboa, Munyaradzi Dimairo

|May 28, 2022

Hypotrichosis simplex of the scalp and peeling skin disease, two sides of the same coin.

P López-Balboa, L Martos-Cabrera, M Ramírez-Lluch

Pageof 1

Frequent Collaborators

Gabriela Petrof

Maria L Bageta

Katie Biggs

Diana Papaioannou

Kate Hutchence

Anna E Martinez

M Ramírez-Lluch

L Noguera-Morel

R González-Sarmiento

A Torrelo

Frequent Collaborators

Gabriela Petrof

Maria L Bageta

Katie Biggs

Diana Papaioannou